Literature DB >> 23548665

Factors associated with the risk of adenoma recurrence in distal and proximal colon.

Adeyinka O Laiyemo1, Chyke Doubeni, Paul F Pinsky, V Paul Doria-Rose, Pamela M Marcus, Robert E Schoen, Elaine Lanza, Amanda J Cross.   

Abstract

BACKGROUND/AIMS: Colonoscopy may be less effective in preventing cancer in the proximal colon. We evaluated whether risk factors for adenoma recurrence exhibit differential effect on adenoma recurrence by colon subsite.
METHODS: We examined the association of age, sex, body mass index, smoking status and use of nonsteroidal anti-inflammatory drugs (NSAIDs) on proximal and distal adenoma recurrence among 1,864 participants in the Polyp Prevention Trial. We used multinomial logistic regression models to calculate the relative risk ratios (RRR) and 95% CI.
RESULTS: 733 (39.3%) participants had adenoma recurrence (228 distal only, 369 proximal only and 136 synchronous proximal and distal adenoma). When compared to participants without adenoma recurrence, no factor was associated with an increased risk of distal only adenoma recurrence. Age 65-69 years (RRR = 1.47, 95% CI 1.00-2.16), age ≥70 years (RRR = 2.24, 95% CI 1.57-3.20), and male sex (RRR = 1.73, 95% CI 1.32-2.27) were positively associated with proximal only adenoma recurrence. NSAIDs use was associated with a reduced risk of adenoma recurrence by similar magnitude in distal (RRR = 0.78, 95% CI 0.58-1.07) and proximal colon (RRR = 0.77, 95% CI 0.60-1.00).
CONCLUSIONS: We did not find any modifiable risk factor that differentially increases proximal as compared to distal adenoma recurrence to be clinically useful for targeted intervention.
Copyright © 2013 S. Karger AG, Basel.

Entities:  

Mesh:

Year:  2013        PMID: 23548665      PMCID: PMC3755956          DOI: 10.1159/000346281

Source DB:  PubMed          Journal:  Digestion        ISSN: 0012-2823            Impact factor:   3.216


  24 in total

1.  Celecoxib for the prevention of sporadic colorectal adenomas.

Authors:  Monica M Bertagnolli; Craig J Eagle; Ann G Zauber; Mark Redston; Scott D Solomon; KyungMann Kim; Jie Tang; Rebecca B Rosenstein; Janet Wittes; Donald Corle; Timothy M Hess; G Mabel Woloj; Frédéric Boisserie; William F Anderson; Jaye L Viner; Donya Bagheri; John Burn; Daniel C Chung; Thomas Dewar; T Raymond Foley; Neville Hoffman; Finlay Macrae; Ronald E Pruitt; John R Saltzman; Bruce Salzberg; Thomas Sylwestrowicz; Gary B Gordon; Ernest T Hawk
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

2.  Celecoxib for the prevention of colorectal adenomatous polyps.

Authors:  Nadir Arber; Craig J Eagle; Julius Spicak; István Rácz; Petr Dite; Jan Hajer; Miroslav Zavoral; Maria J Lechuga; Paola Gerletti; Jie Tang; Rebecca B Rosenstein; Katie Macdonald; Pritha Bhadra; Robert Fowler; Janet Wittes; Ann G Zauber; Scott D Solomon; Bernard Levin
Journal:  N Engl J Med       Date:  2006-08-31       Impact factor: 91.245

3.  Risk of developing proximal versus distal colorectal cancer after a negative colonoscopy: a population-based study.

Authors:  Josh Lakoff; Lawrence F Paszat; Refik Saskin; Linda Rabeneck
Journal:  Clin Gastroenterol Hepatol       Date:  2008-08-08       Impact factor: 11.382

Review 4.  Considerations regarding the present and future roles of colonoscopy in colorectal cancer prevention.

Authors:  Douglas K Rex; Emely Eid
Journal:  Clin Gastroenterol Hepatol       Date:  2008-05       Impact factor: 11.382

5.  Lack of effect of a low-fat, high-fiber diet on the recurrence of colorectal adenomas. Polyp Prevention Trial Study Group.

Authors:  A Schatzkin; E Lanza; D Corle; P Lance; F Iber; B Caan; M Shike; J Weissfeld; R Burt; M R Cooper; J W Kikendall; J Cahill
Journal:  N Engl J Med       Date:  2000-04-20       Impact factor: 91.245

Review 6.  Nonsteroidal anti-inflammatory drugs and cyclooxygenase-2 inhibitors for primary prevention of colorectal cancer: a systematic review prepared for the U.S. Preventive Services Task Force.

Authors:  Alaa Rostom; Catherine Dubé; Gabriela Lewin; Alexander Tsertsvadze; Nicholas Barrowman; Catherine Code; Margaret Sampson; David Moher
Journal:  Ann Intern Med       Date:  2007-03-06       Impact factor: 25.391

7.  A randomized trial of rofecoxib for the chemoprevention of colorectal adenomas.

Authors:  John A Baron; Robert S Sandler; Robert S Bresalier; Hui Quan; Robert Riddell; Angel Lanas; James A Bolognese; Bettina Oxenius; Kevin Horgan; Susan Loftus; Dion G Morton
Journal:  Gastroenterology       Date:  2006-09-01       Impact factor: 22.682

8.  Association of colonoscopy and death from colorectal cancer.

Authors:  Nancy N Baxter; Meredith A Goldwasser; Lawrence F Paszat; Refik Saskin; David R Urbach; Linda Rabeneck
Journal:  Ann Intern Med       Date:  2008-12-15       Impact factor: 25.391

9.  Postpolypectomy colonoscopy surveillance guidelines: predictive accuracy for advanced adenoma at 4 years.

Authors:  Adeyinka O Laiyemo; Gwen Murphy; Paul S Albert; Leah B Sansbury; Zhuoqiao Wang; Amanda J Cross; Pamela M Marcus; Bette Caan; James R Marshall; Peter Lance; Electra D Paskett; Joel Weissfeld; Martha L Slattery; Randall Burt; Frank Iber; Moshe Shike; J Walter Kikendall; Elaine Lanza; Arthur Schatzkin
Journal:  Ann Intern Med       Date:  2008-03-18       Impact factor: 25.391

10.  The methylator phenotype in microsatellite stable colorectal cancers is characterized by a distinct gene expression profile.

Authors:  M Ferracin; R Gafà; E Miotto; A Veronese; C Pultrone; S Sabbioni; G Lanza; M Negrini
Journal:  J Pathol       Date:  2008-04       Impact factor: 7.996

View more
  3 in total

1.  Comparison of biomarker expression between proximal and distal colorectal adenomas: The Tennessee-Indiana Adenoma Recurrence Study.

Authors:  Timothy Su; M Kay Washington; Reid M Ness; Douglas K Rex; Walter E Smalley; Thomas M Ulbright; Qiuyin Cai; Wei Zheng; Martha J Shrubsole
Journal:  Mol Carcinog       Date:  2016-08-11       Impact factor: 4.784

2.  Too Good to Be True? Evaluation of Colonoscopy Sensitivity Assumptions Used in Policy Models.

Authors:  Carolyn M Rutter; Pedro Nascimento de Lima; Jeffrey K Lee; Jonathan Ozik
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2022-04-01       Impact factor: 4.090

3.  Combined Endoscopic-Robotic Resection of a Giant Polyp to Avoid Colorectal Resection.

Authors:  Montserrat Guraieb-Trueba; Víctor Manuel Rivera-Méndez; Juan Carlos Sánchez-Robles
Journal:  CRSLS       Date:  2021-04-07
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.